NCT00977249View on ClinicalTrials.gov

Varenicline for Long-term Nicotine Replacement Therapy (NRT) Users

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Tobacco Dependence
Interventions
BEHAVIORAL

support and visits

visits at weeks 0,2,4,6,9 and 12 and 12 months

DRUG

varenicline

DRUG

placebo

Trial Locations (1)

2900

RECRUITING

Gentofte Hospital, Copenhagen

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT00977249 - Varenicline for Long-term Nicotine Replacement Therapy (NRT) Users | Biotech Hunter | Biotech Hunter